Efficacy and safety of CD19 directed CAR T-cell therapy for T-cell rich histiocyte rich B-cell lymphoma.
Study #: LY22-02b
Study Status: Published
CD19-directed CART therapy for T cell/histiocyte rich large B-cell lymphoma.
Pophali PA, Fein JA, Ahn KW, Allbee-Johnson M, Ahmed N, Awan FT, Farhan S, Grover NS, Hilal T, Iqbal M, Maakaron J, Modi D, Nasrollahi E, Schachter L, Sauter CS, Hamadani M, Herrera AF, Shouval R, Shadman M.
Blood Advances. 2024, Jul 01: (): . doi: 10.1182/bloodadvances.2024013863. Epub 2024, Jul 01. PMCID:.
PMID: 38985302
Abstract